Adial Pharmaceuticals to present at H.C. Wainwright conference; no material updates disclosed

ADIAL PHARMACEUTICALS, INC.

Company will present at H.C. Wainwright 25th Annual Global Investment Conference Sept 11-13, 2023.
Investor presentation furnished as Exhibit 99.1 contains no new financial or operational data.
No earnings, guidance, or pipeline milestones announced in this filing.
Filing is procedural under Regulation FD; presentation includes standard forward-looking statements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.